According to a new report by Polaris Market Research, the global cancer biomarkers market was valued at USD 26.48 billion in 2025 and is projected to reach USD 68.84 billion by 2034, expanding at a CAGR of 11.2% from 2026 to 2034. Growth is underpinned by rising global cancer prevalence, expanding biomarker discovery technologies, and accelerating adoption of personalized medicine across key...